University of Missouri — Columbia, Missouri

Public research footprint of University of Missouri, compiled from the ClinicalTrials.gov public registry.

937

Registered studies

230

Active

124

Recruiting now

539

Completed

131

Stopped or withdrawn

Most-studied conditions

Botryoid-Type Embryonal Rhabdomyosarcoma · Spindle Cell Rhabdomyosarcoma · Alveolar Rhabdomyosarcoma · Metastatic Malignant Neoplasm in the Bone Marrow

Recently updated registry entries

NCT06158841 — Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard… (Recruiting)
NCT03966027 — Immediate Vs. Delayed Weight Bearing Postoperative Protocol in Diabetic Ankle Fractures (Recruiting)
NCT05407636 — Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Missouri?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.